The size of the Sterile Filtration Market in the Middle East & Africa was valued at USD 0.49 billion in 2022. It is further estimated to be growing at a CAGR of 7.46% and value USD 0.71 billion by 2027.
Sterilization is the procedure that helps in destroying all forms of microbial life and transmissible agents. Some of the transmissible agents are bacteria, spore forms, fungi and viruses. These transmissible agents and micro-organisms are present on the surface of medical instruments, contained in medication, fluid and biological culture media.
The contraction of pore size in the membrane for sterilization, it turns out that simple size selection is not enough method to fully contain all the particles. The unbalanced and scrambled nature of the pores of most membrane filters makes it impossible to directly measure the size of an individual pore; so, the bubble point test is used to determine the smallest particle that the filter can sieve out of fluid.
Growth in the biopharmaceutical industry, increase in R&D spending, rising incidence of diabetes & kidney failure, growing demand for biopharmaceutical molecules, and increasing purity requirements in the end-user market are driving factors of the market.
Moreover, strict government rules for validation of the filtration process are the major factor restraining the growth of this market.
This research report on the Middle East and Africa Sterile Filtration Market has been segmented and sub-segmented into the following categories:
By Membrane Pore Size:
By End User:
Noteworthy companies operating in the Middle East & Africa Sterile filtration market include Merck & Co., Inc., 3M, General Electric Company, Pall Corporation, Parker Hannifin Corporation, Sartorius Stedim Biotech Group, Porvair Filtration Group, Sterlitech Corporation and Starlab Scientific Co., Ltd.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com